Clinical Trial Update: YL-13027 and/or HY-0102 Combined With AG Regimen Chemotherapy for Metastatic Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/2 study evaluating YL-13027 and HY-0102 in combination with AG regimen chemotherapy for metastatic pancreatic can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• HY-0102
• YL-13027

Snippet

Sponsor: Shanghai YingLi Pharmaceutical Co. Ltd. | Conditions: Metastatic Pancreatic Cancer | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING